摘要
目的：为医疗保险部门制定医院制剂报销政策提供参考。方法：回顾性调查统计我院2013年4月制剂价格调整前后各15个月（2012年1月~2014年6月）的制剂使用情况,分析价格调整与临床用量的关系。结果：价格调整后47种制剂中,9种制剂用量增加,占19.15%;38种用量减少,占80.85%。结论：临床用量与价格调整缺乏直接联系,医院制剂仍是临床用药不可缺少的部分,亟待医疗保险部门调整制剂的医保报销政策,以降低患者负担。
Objective： To provide reference for medical insurance authority to make reimbursement policy on hospital preparations.Methods： The usage of hospital preparations in 15 months before and after the price adjustment in April 2013 was retrospectively investigated in our hospital（ from January 2012 to June 2014）,and the correlation between the price adjustment and the utilization of hospital preparations was analyzed. Results： The usage of 9 kinds（ 19. 15%） of hospital preparations was increased,while that of 38 kinds（ 80. 85%） was decreased after the price adjustment. Conclusion： There is no direct correlation between the usage of hospital preparations and the price adjustment. Hospital preparations are still an indispensable part of medicines for clinical therapy. It is urgent for medical insurance authority to adjust reimbursement policy on hospital preparations in order to reduce the economic burden of patients.
出处
《中国药师》
CAS
2016年第8期1546-1548,共3页
China Pharmacist
关键词
医院制剂
价格调整
临床用量
药品报销
Hospital preparation
Price adjustment
Clinical usage
Drug reimbursement
